Controversies in Vascular Composite Allotransplantation (VCA) Fri, Oct 9

This course will cover the latest trends and developments in vascularized composit allotransplantation, including face, hand, abdominal wall, and genitourinary. Specific focus will be on immunological concepts and cost-benefit analysis of the unique allotransplants.

At the end of this activity participants will be able to:

  1. Discuss the newest cases and latest innovations in VCA as of 2020;
  2. Describe techniques for face, hand, abdominal wall, and genitourinary VCA;
  3. Identify the risks and benefits of different immunosuppressive protocols;
  4. Discuss the financial risks and benefits of starting a VCA program.

Educational Grant Support Provided By: LEADERS: Allergan Aesthetics, an AbbVie Company; Galderma Laboratories, L.P.; Galatea Surgical, Inc.; INNOVATORS: Mentor Worldwide, LLC; SUPPORTERS: Johnson & Johnson Medical Devices Companies

In-Kind Support Provided By: Galatea Surgical, Inc.; Johnson & Johnson Medical Devices Companies

Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.

Designation: The ASPS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.